Role of FKBP5 and its genetic mutations in stress-induced psychiatric disorders: an opportunity for drug discovery
Stress-induced mental health disorders are affecting many people around the world. However, effective drug therapy for curing psychiatric diseases does not occur sufficiently. Many neurotransmitters, hormones, and mechanisms are essential in regulating the body's stress response. One of the mos...
Main Authors: | Mahdi Malekpour, Dorsa Shekouh, Mohammad Ebrahim Safavinia, Shadi Shiralipour, Maryam Jalouli, Sahar Mortezanejad, Negar Azarpira, Niloofar Dehdari Ebrahimi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1182345/full |
Similar Items
-
Pharmacological Modulation of the Psychiatric Risk Factor FKBP51 Alters Efficiency of Common Antidepressant Drugs
by: Max L. Pöhlmann, et al.
Published: (2018-11-01) -
FKBP Ligands—Where We Are and Where to Go?
by: Jürgen M. Kolos, et al.
Published: (2018-12-01) -
Response: Letter to FKBP5 blockade may provide a new horizon for the treatment of stress‐associated disorders: An in silico study
by: Ali A. Asadi‐Pooya
Published: (2023-12-01) -
Association of SNPs in the FK-506 binding protein (FKBP5) gene among Han Chinese women with polycystic ovary syndrome
by: Xinyue Ma, et al.
Published: (2022-07-01) -
Association of FKBP5 polymorphisms with patient susceptibility to coronary artery disease comorbid with depression
by: Haidong Wang, et al.
Published: (2020-06-01)